Skip to main content

Faces of Frailty in Aging with HIV Infection

Current HIV/AIDS Reports volume 14, pages 31–37 (2017)Cite this article

Abstract

Purpose of the Review

The number of adults who are aging successfully and have HIV infection is increasing. More effective antiretroviral therapy (ART) regimens are preventing individuals infected with HIV from reaching end stages of the HIV infection and developing AIDS (acquired immunodeficiency syndrome). However, even at lower viral loads, chronic HIV infection appears to have consequences on aging processes, including the development of frailty.

Recent Findings

Frailty is a term used to describe vulnerability in aging. Frailty indices such as the Fried Frailty Index (FFI), the Veterans Aging Cohort Study (VACS) Index, and the Center for Epidemiologic Studies Depression scale (CES-D), an index of emotional frailty, associate with or predict clinical outcomes and death. However, even among existing frailty definitions, components require rigorous and consistent standardization. In the Women’s Interagency HIV Study (WIHS), we have shown that frailty does not exist in isolation, even in midlife, and we use frailty to predict death.

Summary

Frailty indices should be systematically used by health professionals to evaluate health and future risks for adverse events. Frailty prevention efforts, especially among those with HIV infection, appear to be essential for “successful aging” or aging without disability or loss of independence and may prevent HIV transmission. Taking care of elderly people is one of the major challenges of this century, and we must expect and be prepared for an increase in the number of aging adults, some of whom are patients with many co-morbidities and HIV infection.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. World Health Organization. World report on ageing and health. Geneva: World Health Organization; 2015.

    Google Scholar 

  2. World Health Organization. HIV/AIDS fact sheet. Geneva: World Health Organization; 2016.

    Google Scholar 

  3. Centers for Disease Prevention and Control. HIV among people aged 50 and over. In: Division of HIV/AIDS Prevention NCfHA, Viral Hepatitis, Sexual Transmitted Diseases and Tuberculosis Prevention, editor. Atlanta: Centers for Disease Control and Prevention; 2016.

  4. Desquilbet L, Jacobson LP, Fried LP, et al. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci. 2007;62(11):1279–86.

    Article  PubMed  Google Scholar 

  5. Desquilbet L, Margolick JB, Fried LP, et al. Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. J Acquir Immune Defic Syndr. 2009;50(3):299–306.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Effros RB, Fletcher CV, Gebo K, et al. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis. 2008;47(4):542–53.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Subra J, Gillette-Guyonnet S, Cesari M, Oustric S, Vellas B, Platform T. The integration of frailty into clinical practice: preliminary results from the Gerontopole. J Nutr Health Aging. 2012;16(8):714–20.

    CAS  Article  PubMed  Google Scholar 

  8. Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal. 2001;1:323–36.

    CAS  Article  PubMed  Google Scholar 

  9. Parfentjev IA. Frailty of old age and bacterial allergy. Geriatrics. 1956;11(6):260–2.

    CAS  PubMed  Google Scholar 

  10. Walston J, Hadley EC, Ferrucci L, et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc. 2006;54(6):991–1001.

    Article  PubMed  Google Scholar 

  11. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–56.

    CAS  Article  PubMed  Google Scholar 

  12. Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci. 2007;62(7):722–7.

    Article  PubMed  Google Scholar 

  13. Rockwood K, Mitnitski A. Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriatr Med. 2011;27(1):17–26.

    Article  PubMed  Google Scholar 

  14. Hirsch C, Anderson ML, Newman A, et al. The association of race with frailty: the cardiovascular health study. Ann Epidemiol. 2006;16(7):545–53.

    Article  PubMed  Google Scholar 

  15. Althoff KN, Jacobson LP, Cranston RD, et al. Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men. J Gerontol A Biol Sci Med Sci. 2014;69(2):189–98.

    Article  PubMed  Google Scholar 

  16. Terzian AS, Holman S, Nathwani N, et al. Factors associated with preclinical disability and frailty among HIV-infected and HIV-uninfected women in the era of cART. J Women’s Health (Larchmt). 2009;18(12):1965–74.

    Article  Google Scholar 

  17. Justice AC, Modur SP, Tate JP, et al. Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. J Acquir Immune Defic Syndr. 2013;62(2):149–63.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Escota GV, Patel P, Brooks JT, et al. Short communication: The Veterans Aging Cohort Study Index is an effective tool to assess baseline frailty status in a contemporary cohort of HIV-infected persons. AIDS Res Hum Retrovir. 2015;31(3):313–7.

    CAS  Article  PubMed  Google Scholar 

  19. Justice AC, Dombrowski E, Conigliaro J, et al. Veterans Aging Cohort Study (VACS): overview and description. Med Care. 2006;44(8 Suppl 2):S13–24.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Gustafson DR, Shi Q, Thurn M, et al. Frailty and constellations of factors in aging HIV-infected and uninfected women—the Women’s Interagency HIV Study. J Frailty Aging. 2016;5(1):43–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Cohen MH, Hotton AL, Hershow RC, et al. Gender-related risk factors improve mortality predictive ability of VACS Index among HIV-infected women. J Acquir Immune Defic Syndr. 2015;70(5):538–44.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Verucchi G, Calza L, Manfredi R, Chiodo F. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Infection. 2004;32(1):33–46.

    CAS  Article  PubMed  Google Scholar 

  23. Piggott DA, Muzaale AD, Mehta SH, et al. Frailty, HIV infection, and mortality in an aging cohort of injection drug users. PLoS One. 2013;8(1):e54910.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  24. Lee KA, Gay C, Portillo CJ, et al. Symptom experience in HIV-infected adults: a function of demographic and clinical characteristics. J Pain Symptom Manag. 2009;38(6):882–93.

    Article  Google Scholar 

  25. Kalayjian RC, Landay A, Pollard RB, et al. Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes. J Infect Dis. 2003;187(12):1924–33.

    Article  PubMed  Google Scholar 

  26. Nguyen N, Holodniy M. HIV infection in the elderly. Clin Interv Aging. 2008;3(3):453–72.

    PubMed  PubMed Central  Google Scholar 

  27. Greene M, Covinsky KE, Valcour V, et al. Geriatric syndromes in older HIV-infected adults. J Acquir Immune Defic Syndr. 2015;69(2):161–7.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Desquilbet L, Jacobson LP, Fried LP, et al. A frailty-related phenotype before HAART initiation as an independent risk factor for AIDS or death after HAART among HIV-infected men. J Gerontol A Biol Sci Med Sci. 2011;66(9):1030–8.

    Article  PubMed  Google Scholar 

  29. Onen NF, Overton ET. A review of premature frailty in HIV-infected persons; another manifestation of HIV-related accelerated aging. Curr Aging Sci. 2011;4(1):33–41.

    Article  PubMed  Google Scholar 

  30. Shamliyan T, Talley KM, Ramakrishnan R, Kane RL. Association of frailty with survival: a systematic literature review. Ageing Res Rev. 2013;12(2):719–36.

    Article  PubMed  Google Scholar 

  31. Erlandson KM, Schrack JA, Jankowski CM, Brown TT, Campbell TB. Functional impairment, disability, and frailty in adults aging with HIV-infection. Curr HIV/AIDS Rep. 2014;11(3):279–90.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Cohen MH, French AL, Benning L, et al. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med. 2002;113(2):91–8.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Cook JA, Grey D, Burke J, et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health. 2004;94(7):1133–40.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Coughlin SS. Invited commentary: prevailing over acquired immune deficiency syndrome and depressive symptoms. Am J Epidemiol. 2013;177(2):126–8. discussion 9-30

    Article  PubMed  Google Scholar 

  35. Farinpour R, Miller EN, Satz P, et al. Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study (MACS). J Clin Exp Neuropsychol. 2003;25(5):654–70.

    Article  PubMed  Google Scholar 

  36. Lyketsos CG, Hoover DR, Guccione M, et al. Depressive symptoms as predictors of medical outcomes in HIV infection. Multicenter AIDS Cohort Study JAMA. 1993;270(21):2563–7.

    CAS  PubMed  Google Scholar 

  37. Justice AC, McGinnis KA, Skanderson M, et al. Towards a combined prognostic index for survival in HIV infection: the role of ‘non-HIV’ biomarkers. HIV Med. 2010;11(2):143–51.

    CAS  Article  PubMed  Google Scholar 

  38. Ritchie K, Ritchie CW, Yaffe K, Skoog I, Scarmeas N. Is late-onset Alzheimer’s disease really a disease of midlife? Translational CliRes Clin Interventions. 2015;1:122–30.

    Google Scholar 

  39. Vellas B, Balardy L, Gillette-Guyonnet S, et al. Looking for frailty in community-dwelling older persons: the Gerontopole Frailty Screening Tool (GFST). J Nutr Health Aging. 2013;17(7):629–31.

    CAS  Article  PubMed  Google Scholar 

  40. Afilalo J. Conceptual models of frailty: the sarcopenia phenotype. Can J Cardiol. 2016;32(9):1051–5.

    Article  PubMed  Google Scholar 

  41. Crystal HA, Weedon J, Holman S, et al. Associations of cardiovascular variables and HAART with cognition in middle-aged HIV-infected and uninfected women. J Neurovirol. 2011;17(5):469–76.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Hanna DB, Post WS, Deal JA, et al. HIV infection is associated with progression of subclinical carotid atherosclerosis. Clin Infect Dis. 2015;61(4):640–50.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  43. Kaplan RC, Kingsley LA, Sharrett AR, et al. Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin Infect Dis. 2007;45(8):1074–81.

    Article  PubMed  Google Scholar 

  44. Kaplan RC, Landay AL, Hodis HN, et al. Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment. J Acquir Immune Defic Syndr. 2012;60(4):359–68.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  45. Seaberg EC, Benning L, Sharrett AR, et al. Association between human immunodeficiency virus infection and stiffness of the common carotid artery. Stroke. 2010;41(10):2163–70.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Strawbridge WJ, Shema SJ, Balfour JL, Higby HR, Kaplan GA. Antecedents of frailty over three decades in an older cohort. J Gerontol B Psychol Sci Soc Sci. 1998;53(1):S9–16.

    CAS  Article  PubMed  Google Scholar 

  47. Morley JE, Malmstrom TK, Miller DK. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging. 2012;16(7):601–8.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  48. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of Adl: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914–9.

    CAS  Article  PubMed  Google Scholar 

  49. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.

    CAS  Article  PubMed  Google Scholar 

  50. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;385-401

  51. Graf C. Hartford Institute for Geriatric N. The Lawton instrumental activities of daily living (IADL) scale. Medsurg Nurs. 2008;17(5):343–4.

    PubMed  Google Scholar 

  52. Hays RD, Sherbourne CD, Mazel R. User’s Manual for the Medical Outcomes Study (MOS) Core Measures of Health-Related Quality of Life: Rand Corporation; 1995.

  53. Hall KS, Hendrie HC, Brittain HM. The development of a dementia screening screening interview in two distince languages. Int J Methods Psychiatr Res. 1993;3:1–28.

    Google Scholar 

  54. Sayers SP, Jette AM, Haley SM, Heeren TC, Guralnik JM, Fielding RA. Validation of the late-life function and disability instrument. J Am Geriatr Soc. 2004;52(9):1554–9.

    Article  PubMed  Google Scholar 

  55. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.

    Article  PubMed  Google Scholar 

  56. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge the following: State University of New York Downstate Medical Center institutional research support; the Women’s Interagency HIV Study (WIHS) Collaborative Study Group with centers (Principal Investigators) at New York City/Bronx Consortium (Kathryn Anastos); Brooklyn, NY (Howard Minkoff, Deborah Gustafson); Washington DC, Metropolitan Consortium (Mary Young); the Connie Wofsy Study Consortium of Northern California (Ruth Greenblatt); Los Angeles County/Southern California Consortium (Alexandra Levine); Chicago Consortium (Mardge Cohen); and the Data Coordinating Center (Stephen Gange). The WIHS is funded by the National Institute of Allergy and Infectious Diseases (UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, and UO1-AI-42590) and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (UO1-HD-32632). The study is co-funded by the National Cancer Institute, the National Institute on Drug Abuse, and the National Institute on Deafness and Other Communication Disorders. Funding is also provided by the National Center for Research Resources (UCSF-CTSI Grant Number UL1 RR024131).

Author information

Affiliations

  1. Department of Neurology, State University of New York Downstate Medical Center, 450 Clarkson Avenue, Box 1213, Brooklyn, NY, 11203, USA

    Marion Thurn & Deborah R. Gustafson

Authors
  1. Marion Thurn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Deborah R. Gustafson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Deborah R. Gustafson.

Ethics declarations

All aspects of this review are compliant with the ethical guidelines enforced by the State University of New York Downstate Medical Center, USA.

Conflict of Interest

Marion Thurn and Deborah R. Gustafson have no conflicts of interest to declare.

Human and Animal Rights and Informed Consent

This article contains reference to human research studies, some performed by Dr. Gustafson. All studies cited or conducted within the WIHS are approved by ethical review boards at each WIHS site. The Institutional Review Boards of each WIHS site have reviewed and approved all data collection and analyses for the WIHS.

Disclaimer

The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.

Additional information

This article is part of the Topical Collection on Behavioral-Bio-Medical Interface

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Thurn, M., Gustafson, D.R. Faces of Frailty in Aging with HIV Infection. Curr HIV/AIDS Rep 14, 31–37 (2017). https://doi.org/10.1007/s11904-017-0348-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11904-017-0348-x

Keywords

  • Frailty
  • Elderly
  • HIV
  • Disabilities
  • Assessment
  • Prevention